Search research articles
Contact Us
Filters
Showing results (41-50 of 61) with videos related to
Page
of 7
Sort By:
Urology Practice
|
June 20, 2024
Reply by Authors
Alexander L Sinks, Hailey W Holck, Lila G McGrath, et al.
Urology Practice
|
June 20, 2024
Impact of Socioeconomic Status on Patient Adherence in Managing Renal Masses
Alexander L Sinks, Hailey W Holck, Lila G McGrath, et al.
The Journal of Urology
|
November 13, 2007
The chemokine receptor CXCR3 is an independent prognostic factor in patients with localized clear cell renal cell carcinoma
Tobias Klatte, David B Seligson, John T Leppert, et al.
Urologic Oncology
|
June 25, 2022
Impact of dedicated renal enhanced recovery after surgery (RERAS) program on postoperative opioid consumption and evaluation of surgeon-specific compliance to the program
Emily H Roebuck, Samuel J Ivan, Myra M Robinson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 21, 2007
Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma
Tobias Klatte, David B Seligson, Stephen B Riggs, et al.
Clinical Genitourinary Cancer
|
May 17, 2022
Testis Cancer Care in North Carolina: Implications for Real-World Evidence and Cancer Surveillance
Stephen McMahon, Xi Zhou, Christopher D Baggett, et al.
Urology Practice
|
May 5, 2023
Association of 5-Alpha Reductase Inhibitor Use with Prostate Specific Antigen Level at the Time of Urology Referral in a Retrospective Cohort at a Large, Integrated Health Care System
James T Kearns, Justin T Matulay, William E Anderson, et al.
International Journal of Molecular Sciences
|
July 2, 2021
Macrophages Compensate for Loss of Protein Tyrosine Phosphatase N<sub>2</sub> in Dendritic Cells to Protect from Elevated Colitis
Larissa Hering, Egle Katkeviciute, Marlene Schwarzfischer, et al.
Cancer
|
October 1, 2008
Cancer-specific survival outcomes among patients treated during the cytokine era of kidney cancer (1989-2005): a benchmark for emerging targeted cancer therapies
Arie S Belldegrun, Tobias Klatte, Brian Shuch, et al.
BJUI Compass
|
February 6, 2026
Racial and socioeconomic disparities from time of diagnosis to treatment for small renal masses
Lila G McGrath, Hailey W Holck, Anthony J Teixeira, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 61) with videos related to
Sort By:
Page
of 7
Urology Practice
|
June 20, 2024
Reply by Authors
Alexander L Sinks, Hailey W Holck, Lila G McGrath, et al.
Urology Practice
|
June 20, 2024
Impact of Socioeconomic Status on Patient Adherence in Managing Renal Masses
Alexander L Sinks, Hailey W Holck, Lila G McGrath, et al.
The Journal of Urology
|
November 13, 2007
The chemokine receptor CXCR3 is an independent prognostic factor in patients with localized clear cell renal cell carcinoma
Tobias Klatte, David B Seligson, John T Leppert, et al.
Urologic Oncology
|
June 25, 2022
Impact of dedicated renal enhanced recovery after surgery (RERAS) program on postoperative opioid consumption and evaluation of surgeon-specific compliance to the program
Emily H Roebuck, Samuel J Ivan, Myra M Robinson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 21, 2007
Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma
Tobias Klatte, David B Seligson, Stephen B Riggs, et al.
Clinical Genitourinary Cancer
|
May 17, 2022
Testis Cancer Care in North Carolina: Implications for Real-World Evidence and Cancer Surveillance
Stephen McMahon, Xi Zhou, Christopher D Baggett, et al.
Urology Practice
|
May 5, 2023
Association of 5-Alpha Reductase Inhibitor Use with Prostate Specific Antigen Level at the Time of Urology Referral in a Retrospective Cohort at a Large, Integrated Health Care System
James T Kearns, Justin T Matulay, William E Anderson, et al.
International Journal of Molecular Sciences
|
July 2, 2021
Macrophages Compensate for Loss of Protein Tyrosine Phosphatase N<sub>2</sub> in Dendritic Cells to Protect from Elevated Colitis
Larissa Hering, Egle Katkeviciute, Marlene Schwarzfischer, et al.
Cancer
|
October 1, 2008
Cancer-specific survival outcomes among patients treated during the cytokine era of kidney cancer (1989-2005): a benchmark for emerging targeted cancer therapies
Arie S Belldegrun, Tobias Klatte, Brian Shuch, et al.
BJUI Compass
|
February 6, 2026
Racial and socioeconomic disparities from time of diagnosis to treatment for small renal masses
Lila G McGrath, Hailey W Holck, Anthony J Teixeira, et al.
Page
of 7